Trial Profile
A Prospective, Pilot Trial to Evaluate Safety and Tolerability of Tacrolimus Extended-Release (Astagraf XL) in HLA Sensitized Kidney Transplant Recipients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Jan 2022
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary) ; Alemtuzumab; Immune globulin; Mycophenolate mofetil; Mycophenolate sodium; Prednisone; Rituximab
- Indications Transplant rejection
- Focus Adverse reactions
- 03 Dec 2021 Status changed from active, no longer recruiting to completed.
- 06 May 2020 Planned primary completion date changed from 9 May 2020 to 9 Nov 2020.
- 06 May 2020 Status changed from recruiting to active, no longer recruiting.